Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06918223 · ClinicalTrials.gov registry record · NA

Assessing Patient Satisfaction and Confidence After Use of Educational Video to Augment Surgical Consent for Thyroid Surgery

A NA study of Thyroid Cancer, sponsored by Thomas Jefferson University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06918223: Recruiting NA study of Thyroid Cancer, sponsored by Thomas Jefferson University.

NCT06918223 is a NA study of Thyroid Cancer that is actively recruiting participants, run by Thomas Jefferson University. The registered enrollment target is 60 participants, below the 280-participant average among 46 other Thyroid Cancer trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06918223, a NA study of Thyroid Cancer, is actively recruiting participants, sponsored by Thomas Jefferson University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This study looks at how a short educational video can help people better understand thyroid surgery. Patients who have thyroid nodules and need surgery will be part of the study. Some patients will get the usual information from their doctor, while others will also watch a video that explains the surgery in a simple and clear way. The study will check if the video helps patients feel more confident about their decision, lowers anxiety, and helps them remember important information about their surgery. Patients will answer surveys before surgery, after surgery, and 3 months later.

Primary Outcome

This outcome measures patient knowledge of thyroid surgery, including indications, procedural options, risks, and benefits. A 10-question internally developed and validated multiple-choice questionnaire will be administered before and after the informed consent process. Each correct answer is scored as 1 point, with a total score ranging from 0 to 10. Higher scores indicate greater understanding and retention of surgical information.

Conditions Studied

Interventions

  • BEHAVIORAL Thyroid Informed Surgical Consent Augmenting Video (TISCAV)
  • BEHAVIORAL Standard Consent

Study Locations (1)

Pennsylvania

  • Thomas Jefferson University - Philadelphia

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2023-11-10
Est. Completion 2025-12
Phase NA
Thomas Jefferson University

292 total trials

What NCT06918223 shows while recruiting

NCT06918223 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 280-participant average among 46 other Thyroid Cancer trials with a reported enrollment target (79% lower).

The record links to 1 condition, with Thyroid Cancer appearing as the primary indexed condition, and to 2 interventions - of which Thyroid Informed Surgical Consent Augmenting Video (TISCAV) is the first listed.

NCT06918223 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06918223 about?

NCT06918223 is a clinical study titled "Assessing Patient Satisfaction and Confidence After Use of Educational Video to Augment Surgical Consent for Thyroid Surgery". This study looks at how a short educational video can help people better understand thyroid surgery. Patients who have thyroid nodules and need surgery will be part of the study. Some patients will get the usual information from their doctor, while others will also watch a video that explains the su...

What is the current status of trial NCT06918223?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2023-11-10. Estimated completion is 2025-12.

What conditions does trial NCT06918223 study?

This clinical trial studies the following conditions: Thyroid Cancer.

What interventions are being tested in trial NCT06918223?

The interventions under investigation include: Thyroid Informed Surgical Consent Augmenting Video (TISCAV) (BEHAVIORAL), Standard Consent (BEHAVIORAL).

Who is sponsoring clinical trial NCT06918223?

This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06918223 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Thyroid Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06918223's enrollment target sits among peer trials

60 24th of 46 higher than 23 of 46 other Thyroid Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Thyroid Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06918223, the US trial registry maintained by the National Library of Medicine. NCT06918223 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.